Equity Capital Markets

Company · CIK 811641

IMMUCELL CORP /DE/

CIK811641 (SEC EDGAR)
Industry (SIC)2835 — In Vitro & In Vivo Diagnostic Substances
Incorporated inDE
Business addressME
ListedICCC (Nasdaq)
First annual or quarterly report1995-08-03

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-278438
ShelfEffective
 2024-04-012024-04-092
333-228479
ShelfEffective
 2018-11-202021-04-165
333-207635
ShelfEffective
 2015-10-272017-12-196
333-214641
ShelfEffective
 2016-11-162016-12-142

Filings

15
FiledFilingRegistrationAccession
2024-04-09EFFECTDeclared effective 333-2784389999999995-24-000907
2024-04-01S-3Shelf registered 333-2784380001213900-24-028881
2021-04-16424B5Shelf takedown 333-2284790001213900-21-021847
2019-03-27424B5Shelf takedown 333-2284790001213900-19-004959
2019-03-26424B5Shelf takedown 333-2284790001213900-19-004861
2018-11-29EFFECTDeclared effective 333-2284799999999995-18-003000
2018-11-20S-3Shelf registered 333-2284790001213900-18-016275
2017-12-19424B5Shelf takedown 333-2076350001213900-17-013430
2017-07-27424B5Shelf takedown 333-2076350001213900-17-007981
2016-12-14EFFECTDeclared effective 333-2146419999999995-16-006451
2016-11-16S-3Shelf registered 333-2146410001213900-16-018648
2016-01-29424B5Shelf takedown 333-2076350001213900-16-010448
2016-01-28424B5Shelf takedown 333-2076350001213900-16-010444
2015-11-10EFFECTDeclared effective 333-2076359999999995-15-003017
2015-10-27S-3Shelf registered 333-2076350001213900-15-007957

All filings of this company · CSV